Brief: Medigene says 9M immunotherapy revenue 3.4 mln eur

Medigene AG

09/11/2017 06:30

Nov 9 (Reuters) - Medigene  MDG1k.DE  
    * Says confirms its financial guidance for 2017 
    * Says 9M revenue from core business immunotherapies 
(bluebird bio 
partnership) of eur 3.435 million 
    * Says 9M total revenue eur 7.176 million (9M 2016: eur 
7.052 
million) 
    * Says 9M EBITDA loss increased as planned to eur 10.143 
million 
(9M 2016: eur 9.095 million) 
 
Source text for Eikon:  ID:nPexKf55ha  
Further company coverage:  MDG1K.DE  
 
 ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;))